Correspondence 0001628280-25-017367 from LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc.
Date: April 10, 2025 · CIK: 0001815776 · Accession: 0001628280-25-017367
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286398
Letter
Document April 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Doris Stacey Gama Re: LENZ Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-286398 Acceleration Request Requested Date: April 14, 2025 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “ Company ”) hereby requests that its Registration Statement on Form S-3 (File No. 333-286398) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237. Sincerely, LENZ THERAPEUTICS, INC. By: /s/ Evert Schimmelpennink Evert Schimmelpennink Chief Executive Officer cc: Daniel Chevallard, LENZ Therapeutics, Inc. Dan Koeppen, Wilson Sonsini Goodrich & Rosati Ben Capps, Wilson Sonsini Goodrich & Rosati
Show Raw Text
CORRESP 1 filename1.htm Document April 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Doris Stacey Gama Re: LENZ Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-286398 Acceleration Request Requested Date: April 14, 2025 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “ Company ”) hereby requests that its Registration Statement on Form S-3 (File No. 333-286398) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237. Sincerely, LENZ THERAPEUTICS, INC. By: /s/ Evert Schimmelpennink Evert Schimmelpennink Chief Executive Officer cc: Daniel Chevallard, LENZ Therapeutics, Inc. Dan Koeppen, Wilson Sonsini Goodrich & Rosati Ben Capps, Wilson Sonsini Goodrich & Rosati